June 26-28, 2018

Frankfurt, Germany

Why sponsor?

The Armed Oncolytic Immunotherapy Summit is the leading dedicated meeting focused on the next generation of oncolytic viral and microbe therapies.

This meeting discusses the challenges limiting the clinical development of oncolytic immunotherapies with the largest hurdles involving process development and manufacturing aspects to produce quality viruses at a scale suitable for commercialization.

As oncolytic immunotherapies continue their momentum moving into clinical translation and seek external expertise – are you front of mind?

Showcase Expertise and Build Credibility 

Pharma, biotech and research institutes are actively seeking solution providers to support their efforts to advance clinical translation of oncolytic immunotherapies. Take this opportunity to advertise your clinical expertise and make your services clear to the decision makers in this space.

Build Relationships With Senior Level Decision Makers 

This is your opportunity to network and interact with all of the leading members of the immuno-oncolytic community in one room over three days. Network and discuss with the companies decision makers and hear first hand on the challenges they face and the solutions that they seek.

Drive Brand to Forefront of Mind 

As the leading drug developers seek out-of-house expertise are you front of mind? Take this chance to benefit from pre and post conference exposure to our immuno-oncology community. Differentiate your company from other solution providers to ensure you identify as a key leader of the immuno-oncology space.

Partnering with the Armed Oncolytic Immunotherapy Summit will ensure you capitalize on the market early, cement your position as an industry leader and support the rate of discovery and clinical development of safe and effective armed oncolytic immunotherapies.

For further information please don’t hesitate to send us an email.